Skip to main content
. 2022 Dec 28;12(1):231. doi: 10.3390/jcm12010231

Figure 1.

Figure 1

Algorithm for study participants enrollment and the risk of hepatitis B reactivation in various conditions. CTx, chemotherapy; HBV, hepatitis B virus; ICI, immune checkpoint inhibitor; NUC, nuceos(t)ide analogues; TKI, tyrosine kinase inhibitor.